MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of precision curated regulatory-grade Real World Data (“RWD”), today announced that it has accepted an invitation to join ClinEco Inc., a connectivity platform and community environment, which improves access and expands distribution while promoting streamlined partner interactions and accelerated clinical innovation.
“We are excited to be invited to join this vibrant clinical trial community, which validates that our Real World Data platform is a trusted source for precision regulatory grade clinical data (RWD),” stated Aaron Green, OneMedNet President and CEO. “The effective utilization of Real World Data in clinical research is rapidly increasing and, as with many high growth market segments, there is a need for all participants to connect and grow together. We believe ClinEco will be a valuable platform for us to both educate, and efficiently provide specific and precise high quality RWD driving insights for Life Science members.”
ClinEco (short for Clinical Ecosystem) is the world’s first B2B market network for clinical trials, uniting sponsors, CROs, service providers, and sites on the world’s largest clinical trial marketplace enabling members to explore, engage, and exchange capabilities with their own ecosystem of partners. ClinEco was designed by the creators of SCOPE (Summit for Clinical Ops Executives).
About OneMedNet Corporation
Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical data repositories of healthcare providers. OneMedNet's robust iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records (EHR), laboratory results, medical imaging data. Employing its proven OneMedNet iRWD™ platform, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to healthcare providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements.
The OneMedNet iRWD™ network consists of 290+ facilities from leading healthcare systems and providers. Our commitment to growing our platform to provide near real time real-world data translates into healthcare innovations, setting new standards in patient care and advancing the future of medicine. For more information about OneMedNet Corporation, please visit www.onemednet.com.
About ClinEco
ClinEco unites sponsors, CROs, service providers, and sites on the world's first B2B clinical trial marketplace, empowering all to expand clinical partnerships. By creating a platform where all research stakeholders can explore, engage, and exchange capabilities with an ecosystem of partners, ClinEco accelerates the process of vendor selection, leading to faster, more efficient clinical trials. ClinEco is a Cambridge Healthtech Institute Company. Learn more about the ClinEco community by visiting http://clineco.io.
Company Contact:
OneMedNet Corporation
Michael Wong, Director of Marketing
Phone: 800.918.7189
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.97 |
Daily Change: | 0.04 4.08 |
Daily Volume: | 462,777 |
Market Cap: | US$27.150M |
December 02, 2024 September 26, 2024 July 26, 2024 June 14, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB